John Lewicki, PhD, Senior Vice President, Research and Development

John Lewicki joined Oncomed after serving 16 years with Scios Inc., where he managed the company's research organization across diverse therapeutic areas. Among his many achievements with that organization was the co-discovery of Natrecor™, an FDA approved drug for congestive heart failure. Most recently, Dr. Lewicki has been Sr. VP, Research and Development of an early-stage biotechnology company working in the infectious disease field.

Dr. Lewicki received his PhD in Physiology/Pharmacology from UC San Diego and conducted his post-doctoral training at University of Virginia and Stanford University. He is the author of more than 70 research papers and book chapters and is an inventor on 22 issued US patents.